These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24223657)

  • 21. Demethylation of CDKN2A in systemic lupus erythematosus and rheumatoid arthritis: a blood biomarker for diagnosis and assessment of disease activity.
    Gravand A; Alesaeidi S; Khoshbakht S; Saghaei M; Kenarangi T; Mosallaei M; Soosanabadi M
    Clin Rheumatol; 2023 Dec; 42(12):3387-3395. PubMed ID: 37597101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
    Erhardt CC; Mumford P; Maini RN
    Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
    Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
    Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus].
    Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195
    [No Abstract]   [Full Text] [Related]  

  • 26. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
    Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
    Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.
    Bertouch JV; Roberts-Thompson PJ; Feng PH; Bradley J
    Ann Rheum Dis; 1983 Dec; 42(6):655-8. PubMed ID: 6606401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus.
    Pradhan V; Rajadhyaksha A; Yadav K; Surve P; Patwardhan M; Dhavale N; Pandit P; Ghosh K
    Indian J Nephrol; 2013 Nov; 23(6):434-7. PubMed ID: 24339522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
    Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
    Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semaphorin 4A as a Potential Biomarker for Diagnosis of Systemic Lupus Erythematosus.
    He R; Tan X; Xiang J; Zhu J; Jiang Y; Liu W; Li Y; Guo B; Xing Y
    Immunol Invest; 2023 Jan; 52(1):104-116. PubMed ID: 36239661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum phosphatidylserine-specific phospholipase A
    Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y
    Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
    Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
    Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M; Todoroki T; Sakai K; Nobunaga M
    J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
    Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
    Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Mean Platelet Volume in Patients with Systemic Lupus Erythematosus.
    Hartmann LT; Alegretti AP; Machado ABMP; Martins EF; da Silva Chakr RM; Gasparin AA; Monticielo OA
    Open Rheumatol J; 2018; 12():129-138. PubMed ID: 30258502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group.
    Ricker DM; Hebert LA; Rohde R; Sedmak DD; Lewis EJ; Clough JD
    Am J Kidney Dis; 1991 Dec; 18(6):678-85. PubMed ID: 1962653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.